Loading...
•
Jun 30, 2025
Artivion Q2 2025 Earnings Report
Artivion reported strong second quarter 2025 financial results, with significant revenue growth and increased profitability driven by strong performance in On-X and stent grafts.
Key Takeaways
Artivion delivered an exceptionally strong second quarter in 2025, achieving $113.0 million in revenue, a 15% increase year-over-year. The company reported a net income of $1.3 million and a non-GAAP net income of $10.7 million. Adjusted EBITDA saw a substantial 33% increase to $24.8 million, demonstrating the company's ability to scale and expand margins. Key drivers for revenue growth included On-X and stent grafts, both growing over 20% on a constant currency basis.
Total revenue for Q2 2025 reached $113.0 million, marking a 15% increase from Q2 2024.
Net income for the quarter was $1.3 million, with non-GAAP net income at $10.7 million.
Adjusted EBITDA significantly increased by 33% to $24.8 million in Q2 2025.
The company received IDE approval for the ARTIZEN pivotal trial and successfully retired $99.5 million in convertible senior notes, improving its capital structure.
Revenue by Segment
Revenue by Geographic Location
Forward Guidance
Artivion is raising the midpoint of its full-year 2025 constant currency revenue and adjusted EBITDA guidance, reflecting strong Q2 performance and continued business momentum.
Positive Outlook
- Full-year 2025 constant currency revenue growth expected to be 12% to 14%, up from 11% to 14%.
- Reported revenues for full-year 2025 expected to be in the range of $435 million to $443 million, up from $423 million to $435 million.
- Adjusted EBITDA growth for full-year 2025 expected to be between 21% and 28%, up from 18% to 28%.
- Adjusted EBITDA for full-year 2025 expected to be in the range of $86 million to $91 million, up from $84 million to $91 million.
- Confidence in growing adjusted EBITDA at twice the rate of constant currency revenue growth.
Challenges Ahead
- Financial performance for 2025 and future periods is subject to various risks.
- Unpredictability of the timing and outcome of regulatory decisions and other regulatory developments.
- Risks relating to international operations.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...